Oorsprong van het eerstegraads netwerk van Bob Duisters
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Brabantse Ontwikkelings Maatschappij Holding BV
 Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance Brabantse Ontwikkelings Maatschappij Holding BV (BOM) is an industrial and economic development agency headquarterd in Tilburg in the southern Netherlands. Established in 1983, BOM is funded and financed by the Dutch State and the Province of Noord-Brabant. The firm offers a range of services designed to create, develop, maintain and improve the industrial structure of the region through four core activities: venture capital, foreign investment, new business and industrial parks. In particular BOM manages the Technostartersfonds, also known as the TechnoStars funds, which are regional venture capital investment vehicles based in Eindhoven. The investors are primarily institutions and high-net worth private individuals.
3
| Private Company | Investment Managers | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bob Duisters via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Analyst-Equity | |
Citryll BV
 Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chief Operating Officer | |
| ABN AMRO Bank NV (Broker) | Investment Banks/Brokers | Analyst-Fixed Income | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
| Delft University of Technology | College/University | Graduate Degree | |
Netherlands Foreign Investment Agency
 Netherlands Foreign Investment Agency Financial ConglomeratesFinance The Netherlands Foreign Investment Agency provides business investment services. The private company is based in San Francisco, CA and has subsidiaries in the Netherlands. | Financial Conglomerates | Director/Board Member | |
| University of Groningen | College/University | Graduate Degree | |
| Hanzehogeschool Groningen | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Nederland | 7 |
| Verenigde Staten | 3 |
Sectoraal
| Consumer Services | 5 |
| Finance | 4 |
| Commercial Services | 2 |
Operationeel
| Private Equity Investor | 3 |
| Undergraduate Degree | 2 |
| Graduate Degree | 2 |
| Analyst-Equity | 1 |
| Private Equity Analyst | 1 |
Sterkste connecties
- Beurs
- Insiders
- Bob Duisters
- Bedrijfsconnecties
